T1	CHEM 19 41	vacuna antineumocócica
#1	AnnotatorNotes T1	C0358314; Pneumococcal vaccine; Pharmacologic Substance
T2	CHEM 110 132	vacuna antineumocócica
#2	AnnotatorNotes T2	C0358314; Pneumococcal vaccine; Pharmacologic Substance
T3	PROC 173 183	prevención
#3	AnnotatorNotes T3	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T4	DISO 208 217	infección
#4	AnnotatorNotes T4	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T5	PROC 423 445	evaluar la efectividad
T6	CHEM 452 474	vacuna antineumocócica
#5	AnnotatorNotes T6	C0358314; Pneumococcal vaccine; Pharmacologic Substance
T7	PROC 492 501	vacunados
#6	AnnotatorNotes T7	C0042196; Vaccination; Therapeutic or Preventive Procedure
T8	PROC 507 516	vacunados
#7	AnnotatorNotes T8	C0042196; Vaccination; Therapeutic or Preventive Procedure
T9	DISO 898 907	neumonías
#8	AnnotatorNotes T9	C0032285; Pneumonia; Disease or Syndrome
T10	PROC 802 811	vacunados
#9	AnnotatorNotes T10	C0042196; Vaccination; Therapeutic or Preventive Procedure
T11	PROC 834 843	vacunados
#10	AnnotatorNotes T11	C0042196; Vaccination; Therapeutic or Preventive Procedure
T12	DISO 1072 1080	neumonía
#11	AnnotatorNotes T12	C0032285; Pneumonia; Disease or Syndrome
T13	PROC 1198 1206	vacunada
#12	AnnotatorNotes T13	C0042196; Vaccination; Therapeutic or Preventive Procedure
T14	DISO 1373 1382	neumonías
#13	AnnotatorNotes T14	C0032285; Pneumonia; Disease or Syndrome
T15	DISO 1521 1530	infección
#14	AnnotatorNotes T15	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T16	CHEM 338 344	vacuna
#15	AnnotatorNotes T16	C0042210; Vaccines; Immunologic Factor · Amino Acid, Peptide, or Protein · Pharmacologic Substance
T17	PROC 661 694	estudio de cohortes retrospectivo
#16	AnnotatorNotes T17	C2985505; Retrospective Cohort Study; Research Activity
T18	LIVB 45 54	pacientes
#17	AnnotatorNotes T18	C0030705; Patients; Patient or Disabled Group
T19	Age 55 73	mayores de 65 años
T20	Date 223 234	actualmente
T22	LIVB 482 490	cohortes
#18	AnnotatorNotes T22	C0599755; Cohort; Population Group
T23	Neg_cue 504 506	no
T24	LIVB 521 529	personas
#19	AnnotatorNotes T24	C0027361; Persons; Population Group
T25	Age 530 548	mayores de 65 años
T26	LIVB 640 648	cohortes
#20	AnnotatorNotes T26	C0599755; Cohort; Population Group
T27	LIVB 757 777	cohortes de personas
#21	AnnotatorNotes T27	C0599755; Cohort; Population Group; Cohort; Population Group + C0027361; Persons; Population Group
T29	Age 778 796	mayores de 65 años
T30	Date 820 824	1993
T31	Neg_cue 831 833	no
T32	Date 856 869	la actualidad
T33	Date 937 941	1994
T34	Date 942 946	1999
T35	Frequency 1063 1068	anual
T36	LIVB 1098 1106	personas
#22	AnnotatorNotes T36	C0027361; Persons; Population Group
T37	Age 1107 1125	mayores de 65 años
T39	LIVB 1190 1197	cohorte
#23	AnnotatorNotes T39	C0599755; Cohort; Population Group
T41	LIVB 1392 1400	cohortes
#24	AnnotatorNotes T41	C0599755; Cohort; Population Group
T45	LIVB 286 303	población anciana
#25	AnnotatorNotes T45	C1257890; Population; Population Group + C0001792; Elderly (population group); Population Group
T46	LIVB 672 680	cohortes
#26	AnnotatorNotes T46	C0599755; Cohort; Population Group
T21	DISO 621 630	neumonías
#27	AnnotatorNotes T21	C0032285; Pneumonia; Disease or Syndrome
T28	DISO 1610 1619	neumonías
#28	AnnotatorNotes T28	C0032285; Pneumonia; Disease or Syndrome
A1	Population_data T45 Age
A2	Assertion T8 Negated
A3	Assertion T11 Negated
R1	Negation Arg1:T23 Arg2:T8	
R2	Negation Arg1:T31 Arg2:T11	
T38	Observation 1465 1481	efecto protector
A4	Assertion T38 Negated
T40	Neg_cue 1436 1438	no
R3	Negation Arg1:T40 Arg2:T38	
T42	Neg_cue 1235 1237	No
T43	CONC 1249 1260	diferencias
A5	Assertion T43 Negated
#29	AnnotatorNotes T43	C1705241; Delta (difference); Quantitative Concept
R4	Negation Arg1:T42 Arg2:T43	
T44	Neg_cue 1533 1540	tampoco
T47	Observation 1559 1565	efecto
A6	Assertion T47 Negated
R5	Negation Arg1:T44 Arg2:T47	
T48	Spec_cue 263 269	parece
T49	CONC 270 279	disminuir
A7	Assertion T49 Speculated
#30	AnnotatorNotes T49	C0547047; Decrease; Quantitative Concept
R6	Speculation Arg1:T48 Arg2:T49	
R7	Has_Age Arg1:T18 Arg2:T19	
R8	Experiences Arg1:T18 Arg2:T1	
T50	Quantifier_or_Qualifier 136 148	23 serotipos
R9	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T50	
R10	Before Arg1:T3 Arg2:T4	
R13	Experiences Arg1:T45 Arg2:T3	
R14	Experiences Arg1:T45 Arg2:T2	
R15	Experiences Arg1:T22 Arg2:T6	
R16	Experiences Arg1:T22 Arg2:T7	
R17	Experiences Arg1:T22 Arg2:T8	
R18	Has_Age Arg1:T24 Arg2:T25	
R19	Experiences Arg1:T24 Arg2:T8	
R20	Experiences Arg1:T24 Arg2:T7	
R21	Experiences Arg1:T24 Arg2:T6	
T51	CONC 595 613	nivel de severidad
#31	AnnotatorNotes T51	C0457451; Severity score; Quantitative
T52	CONC 573 592	tasas de incidencia
#32	AnnotatorNotes T52	C1708485; Incidence Rate; Temporal Concept
R22	Experiences Arg1:T26 Arg2:T21	
R24	Experiences Arg1:T26 Arg2:T8	
R25	Experiences Arg1:T26 Arg2:T7	
R26	Experiences Arg1:T26 Arg2:T6	
R28	Experiences Arg1:T22 Arg2:T21	
R29	Used_for Arg1:T6 Arg2:T7	
R30	Used_for Arg1:T6 Arg2:T8	
R32	Experiences Arg1:T24 Arg2:T21	
R33	Has_Age Arg1:T46 Arg2:T29	
R34	Has_Age Arg1:T27 Arg2:T29	
R35	Experiences Arg1:T27 Arg2:T10	
R36	Experiences Arg1:T27 Arg2:T11	
R37	Overlap Arg1:T10 Arg2:T30	
R38	Before Arg1:T11 Arg2:T32	
R39	After Arg1:T9 Arg2:T33	
R40	Before Arg1:T9 Arg2:T34	
T53	CONC 959 978	tasas de incidencia
#33	AnnotatorNotes T53	C1708485; Incidence Rate; Temporal Concept
T54	CONC 980 998	grado de severidad
#34	AnnotatorNotes T54	C0457451; Severity score; Quantitative
T55	CONC 1001 1020	índice de letalidad
#35	AnnotatorNotes T55	C0282250; Case Fatality Rate; Quantitative Concept
R41	After Arg1:T53 Arg2:T33	
R42	After Arg1:T54 Arg2:T33	
R43	After Arg1:T55 Arg2:T33	
R44	Before Arg1:T53 Arg2:T34	
R45	Before Arg1:T54 Arg2:T34	
R46	Before Arg1:T55 Arg2:T34	
T56	CONC 1038 1056	tasa de incidencia
#36	AnnotatorNotes T56	C1708485; Incidence Rate; Temporal Concept
R47	Has_Frequency Arg1:T56 Arg2:T35	
R48	Experiences Arg1:T36 Arg2:T12	
R49	Has_Age Arg1:T36 Arg2:T37	
T57	CONC 1166 1181	riesgo relativo
#37	AnnotatorNotes T57	C0242492; Relative Risk; Quantitative Concept
R50	Experiences Arg1:T39 Arg2:T13	
R51	Experiences Arg1:T39 Arg2:T12	
R52	Has_Age Arg1:T39 Arg2:T37	
T58	CONC 1289 1308	índice de letalidad
#38	AnnotatorNotes T58	C0282250; Case Fatality Rate; Quantitative Concept
T59	CONC 1347 1365	grado de severidad
#39	AnnotatorNotes T59	C0457451; Severity score; Quantitative
R53	Experiences Arg1:T41 Arg2:T14	
#40	AnnotatorNotes T47	C1518681; Outcome of Therapy; Finding (?)
T60	CONC 1593 1602	severidad
#41	AnnotatorNotes T60	C0457451; Severity score; Quantitative
R23	Before Arg1:T38 Arg2:T15	
R27	Before Arg1:T38 Arg2:T28	
R31	Before Arg1:T47 Arg2:T28	
R54	Used_for Arg1:T2 Arg2:T3	
T61	Quantifier_or_Qualifier 1261 1275	significativas
A8	Assertion T61 Negated
#42	AnnotatorNotes T61	C0750502; Significant; Idea or Concept
R55	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T61	
R56	Negation Arg1:T42 Arg2:T61	
R11	Experiences Arg1:T45 Arg2:T4	
#43	AnnotatorNotes T5	C1707887; Efficacy Study; Research Activity
#44	AnnotatorNotes T20	C0521116; Current (present time); Temporal Concept
#45	AnnotatorNotes T38	C2712083; Actual Effective Protective Ability; Finding (?)
A9	Experiencer T18 Patient
A10	Experiencer T45 Patient
A11	Experiencer T22 Patient
A12	Experiencer T24 Patient
A13	Experiencer T26 Patient
A14	Experiencer T46 Patient
A15	Experiencer T27 Patient
A16	Experiencer T36 Patient
A17	Experiencer T39 Patient
A18	Experiencer T41 Patient
